Baader Bank Aktiengesellschaft’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$728K Sell
11,770
-12,014
-51% -$961K 0.06% 214
2025
Q4
$2.24M Buy
23,784
+12,598
+113% +$1.24M 0.15% 106
2025
Q3
$1.08M Buy
11,186
+2,997
+37% +$310K 0.07% 177
2025
Q2
$830K Sell
8,189
-2,127
-21% -$215K 0.06% 191
2025
Q1
$1.01M Buy
10,316
+1,696
+20% +$171K 0.08% 171
2024
Q4
$770K Sell
8,620
-997
-10% -$87.8K 0.05% 189
2024
Q3
$782K Buy
+9,617
New +$758K 0.05% 199

Other funds holding BSX

Baader Bank Aktiengesellschaft's BSX Position: Q1 2026 in Review

Baader Bank Aktiengesellschaft reduced its Boston Scientific (BSX) stake by 51% in Q1 2026, selling an estimated $961K and leaving 11,770 shares worth $728K. The position accounts for 0.06% of the portfolio, ranked #214.

Baader Bank Aktiengesellschaft first reported a position in BSX in Q3 2024 and has held it in 7 quarters since. The position peaked at $2.24M in Q4 2025. 1,664 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

  • Baader Bank Aktiengesellschaft held 11,770 shares of Boston Scientific worth $728K as of Q1 2026.
  • Baader Bank Aktiengesellschaft sold 12,014 Boston Scientific shares in Q1 2026, an estimated $961K.
  • Boston Scientific made up 0.06% of Baader Bank Aktiengesellschaft's portfolio in Q1 2026, its #214 holding.
  • Baader Bank Aktiengesellschaft first reported a position in Boston Scientific in Q3 2024 and has held it in 7 quarters since.
  • Baader Bank Aktiengesellschaft's Boston Scientific position peaked at $2.24M in Q4 2025.
  • 1,664 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on Baader Bank Aktiengesellschaft's 13F filing for Q1 2026, filed 8 May 2026.